You searched for - Page 295 of 6584 - KFF Health News

US Preps For Possible Pandemic, Taps Moderna To Make Bird Flu Vaccine

July 3, 2024 Morning Briefing

As the virus spreads to more cattle and poultry, the government also enlisted commercial labs to help amp up its supply of tests that would detect the H5N1 bird flu in humans. Meanwhile, as covid cases soar in Western states, the NIH begins testing its nasal covid vaccine.

White House Clarifies Where It Stands On Gender-Affirming Care For Children

July 3, 2024 Morning Briefing

“We believe these surgeries should be limited to adults,” a White House spokesperson told The 19th in an email Tuesday. “We continue to support gender-affirming care for minors, which represents a continuum of care.”

DOJ Opens Investigation Into Potential Fraud At Prospect Medical Holdings

July 3, 2024 Morning Briefing

In other industry news, UCSF must continue charity care, stick to price growth caps and more to allow its $100 million takeover of St. Mary’s Medical Center and Saint Francis Memorial Hospital; Walmart has been looking for buyers for its shuttered medical clinics; and more.

FDA Bans Brominated Vegetable Oil In Foods Over Safety Concerns

July 3, 2024 Morning Briefing

The chemical, which is used as a flavor additive but is also used separately in fire retardants, is no longer considered safe. Meanwhile, the CDC and FDA have said the salmonella outbreak in cucumbers has been linked to a Florida grower.

Massachusetts Bill Takes Steps Against Sexual Assaults By Medical Staff

July 3, 2024 Morning Briefing

The bill would also cover clergy members and is aimed at protecting patients who suffer inappropriate contact or assault. Meanwhile, Boston has ended funding for a needle collection program, and West Nile virus was detected in the state for the first time this year.

Morning Briefing for Wednesday, July 3, 2024

July 3, 2024 Morning Briefing

Unaffordable health care, Alzheimer’s drug, Medicaid ‘unwinding,’ emergency abortion aid, HIV, bird flu, drug costs, and more are in the news.

Providers Must Render Emergency Abortion Aid, Feds Reiterate

July 3, 2024 Morning Briefing

Whether providers offer stabilizing medical care themselves or secure alternate out-of-state care, patients are protected under federal law, the Biden administration says. Separately, abortion ban news from Wisconsin, Arizona, and Texas.

FDA Approves Second Drug Aimed At Slowing Progression Of Alzheimer’s

July 3, 2024 Morning Briefing

The FDA approved Tuesday Eli Lilly’s early Alzheimer’s treatment. The monoclonal antibody donanemab, which will be sold under the name Kisunla, is designed to clear amyloid in the brain.

Survey Of People Disenrolled From Medicaid Found Cost, Access Troubles

July 3, 2024 Morning Briefing

A survey of Arkansas, Kentucky, Louisiana, and Texas residents who lost Medicaid coverage once states began reviewing eligibility following the pandemic found that at least half of them were uninsured at the end of 2023. The loss of benefits also led to higher costs for health care or more limited access.

Health Care Agencies Reeling After Supreme Court Stunners

July 3, 2024 Morning Briefing

The end of the Supreme Court’s term delivered a series of shocking decision that will have longterm impact on the health care industry as well as federal agencies’ ability to protect public health.

PEPFAR Funding To Be Cut At Least 6% Amid Budget Fight Over AIDS Program

July 3, 2024 Morning Briefing

A senior official for the President’s Emergency Plan for AIDS Relief (PEPFAR) told Politico about the cuts, which the State Department confirmed. The State Department will soon announce its final country-by-country budgets, the State Department spokesperson said.

First Edition: July 3, 2024

July 3, 2024 Morning Briefing

Here are today’s early morning highlights from the major news organizations. Note to readers: KFF Health News’ First Edition will not be published July 4-5 in observance of Independence Day. Look for it again in your inbox on Monday. Happy Fourth!

Lack of Affordability Tops Older Americans’ List of Health Care Worries

By Judith Graham Updated July 10, 2024 Originally Published July 3, 2024 KFF Health News Original

Rising health care costs are fueling anxiety among older Americans covered by Medicare. They’re right to be concerned.

Beyond PMS: A Poorly Understood Disorder Means Periods of Despair for Some Women

By Lauren Peace, Tampa Bay Times July 3, 2024 KFF Health News Original

Premenstrual dysphoric disorder is estimated to affect around 5% of people who menstruate, but a lack of research and limited awareness of menstrual disorders — even among health care providers — can make getting care difficult.

Parsing Policy: The Real Reason Medicine Costs So Much; Why Fewer Docs Want To Be A Pediatrician

July 2, 2024 Morning Briefing

Opinion writers discuss these topics and others.

Potassium Chloride Capsules Recalled For Irregular Heartbeat Risk

July 2, 2024 Morning Briefing

Included in the voluntary recall are 114 batches of Glenmark Pharmaceuticals extended-release capsules. In other news: Only 18% of eligible Americans are up to date on lung cancer screenings; hoarding disorder rises; an anti-noise advocacy group sues the EPA; and more.

Morning Briefing for Tuesday, July 2, 2024

July 2, 2024 Morning Briefing

Doctor shortages, a fake therapist, worker heat protections, generics dispute, abortion ballot measures, pain, covid, and more are in the news.

National Protections For Workers In Extreme Heat Proposed By Biden

July 2, 2024 Morning Briefing

The Biden administration released a proposal that would put in place the first-ever national protections for people who work in extreme heat. The measure, if finalized, would require rest breaks and access to shade and water.

Wyoming’s Ban On Transgender Minor Care Takes Effect

July 2, 2024 Morning Briefing

Puberty blockers and hormone therapy for transgender youth are now restricted in Wyoming. Meanwhile, in West Virginia, students on university and college campuses are allowed to carry guns. In Mississippi, a law restricting young people’s social media use was blocked.

FTC Investigating Teva Over Contested Patents On Inhalers

July 2, 2024 Morning Briefing

The Federal Trade Commission has ordered Teva Pharmaceuticals to provide internal documents about its patents on asthma and COPD inhalers. The move is part of a larger dispute over minor tweaks made by pharmaceutical companies to products to fend off generics competition, resulting in higher prices for patients.

Filter Results

More From KFF Health News